In esophageal adenocarcinoma, SerpinB3/4 expression has been associated with reduced tumor chemosensitivity as well as the impairment of immune surveillance, leading to a poor prognosis [45]. Here, SERPINB3 is linked to esophageal adenocarcinoma.